Loading...
Loading...
By MBN Staff - Mon, 02/17/2025 - 08:00
Johnson & Johnson’s new data on nipocalimab shows its high-affinity binding, supporting its potential for IgG-driven alloantibody diseases
Featured content
Partnership Content
https://mexicobusiness.news/tag/breakthrough-therapy
More Health
By MBN Staff - Tue, 10/15/2024 - 10:07
Boehringer Ingelheim's survodutide gains FDA Breakthrough Therapy designation for MASH, advancing treatment options.
